pyrimidine has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, Y; Niizuma, K; Rashad, S; Saigusa, D; Saito, R; Tominaga, T; Tomioka, Y; Uruno, A; Yamamoto, M; Yamazaki, T | 1 |
| Inoue, T; Kamei, K; Katsuragi-Ogino, R; Koyama, M; Maeda, N; Nakajima, M; Ohno, T; Tatsuoka, T | 1 |
2 other study(ies) available for pyrimidine and Brain Ischemia
| Article | Year |
|---|---|
Metabolic basis of neuronal vulnerability to ischemia; an in vivo untargeted metabolomics approach.
Topics: Animals; Apoptosis; Brain Ischemia; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Chromatography, Liquid; Gene Expression Regulation; Humans; Ischemic Attack, Transient; Mass Spectrometry; Metabolomics; Neurons; Purines; Pyrimidines; Rats; Signal Transduction | 2020 |
New piperidinyl- and 1,2,3,6-tetrahydropyridinyl-pyrimidine derivatives as selective 5-HT1A receptor agonists with highly potent anti-ischemic effects.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Circulation; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Piperazines; Pyrimidines; Rats; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 2005 |